Sarcoma: open trials in Poland

16 open trials have a site in Poland. Registry data; only the trial team decides who can take part.

NCT06345729
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
Trial Treatment · Phase 3 · Merck Sharp & Dohme LLC
Pratia S.A., Cracow · Szpital Specjalistyczny Im. Henryka Klimontowicza W Gorlicach, Gorlice · Uniwersytecki Szpital Kliniczny nr 4 w Lublinie, Lublin · Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie, Olsztyn · Wojewodzki Szpital Im. Sw.Ojca Pio W Przemyslu, Peremyshl · Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warsaw
Registry updated 2026-10-26
NCT07871864
Fight Osteosarcoma Through European Research Evolving Study Platform From Diagnosis to Relapse
Trial Treatment · Phase 3 · Gustave Roussy, Cancer Campus, Grand Paris
Instytut Matki i Dziecka, Warsaw
Registry updated 2026-10-26
NCT07883798
Radiotherapy for Gynecologic Cancer With Up to 10 Active Metastatic Lesions
Research · Affidea Nu-med Center of Oncological DIagnostics and Therapy
Affidea NU-MED Centrum Diagnostyki i Terapii Onkologicznej, Zamość
Registry updated 2026-10-23
2022-501180-40-00
International Euro Ewing (iEuroEwing) trial for treatment optimisation in patients with Ewing sarcoma
Trial Treatment · Phase 3 · GPOH gGmbH
Instytut Matki i Dziecka, Warsaw
Registry updated 2026-10-19
NCT07541170
A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)
Trial Treatment · Phase 3 · Hoffmann-La Roche
Centrum Pulmonologii i Torakochirurgii w Bystrej, Bystra · Uniwersyteckie Centrum Kliniczne, Gdansk · Swietokrzyskie Centrum Onkologii Samodzielny Publiczny Zaklad Opieki Zdrowotnej w Kielcach, Kielce · Warminsko-Mazurskie Centrum Chorob Pluc w Olsztynie, Olsztyn · National Institute Of Tuberculosis And Lung Diseases, Warsaw · Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii, Wroclaw
Registry updated 2026-10-13
NCT04031677
Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma
Trial Treatment · Phase 3 · European Organisation for Research and Treatment of Cancer - EORTC
Maria Sklodowska-Curie Memorial Cancer Centre - Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw
Registry updated 2026-10-07
NCT05968768
To Evaluate the Efficacy and Safety of Naxitamab in Patients With Refractory Ewing's Sarcoma (Butterfly)
Trial Treatment · Phase 2 · Anna Raciborska
Mother and Child Institute, Warsaw · Wroclaw Medical University, Wroclaw
Registry updated 2026-10-07
NCT07787429
Evaluation of the Safety and Efficacy of Mifamurtide Versus Standard Treatment With Sorafenib in Patients With High-risk Osteosarcoma
Trial Treatment · Phase 2 · Anna Raciborska
Mother and Child Institute, Warsaw
Registry updated 2026-10-07
NCT07252739
KEYMAKER-U01 Substudy 01J: A Study of Pembrolizumab Plus MK-1084 in Participants With Non-Small Cell Lung Cancer (NSCLC) With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) G12C Mutations (MK-3475-01J/KEYMAKER-U01J)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Uniwersyteckie Centrum Kliniczne, Gdansk · Szpital Wojewodzki im. Mikolaja Kopernika w Koszalinie, Koszalin · Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warsaw
Registry updated 2026-09-02
NCT06263231
A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
Trial Treatment · Phase 3 · Intensity Therapeutics, Inc.
Uniwersyteckie Centrum Kliniczne, Gdansk · Uniwersytecki Szpital Kliniczny w Poznaniu, Poznan · Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warsaw · Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii, Wroclaw
Registry updated 2026-08-11
NCT07377747
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
Research · Australia and New Zealand Sarcoma Association
Maria Sklodowska-Curie - National Research Institute of Oncology, Warsaw
Registry updated 2026-07-15
NCT03093116
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Trial Treatment · Phase 1/2 · Turning Point Therapeutics, Inc.
Uniwersyteckie Centrum Kliniczne, Gdansk · Narodowy Instytut Onkologii im Marii Sklodowskiej Curie Panstwowy Instytut Badawczy, Warsaw
Registry updated 2026-05-27
NCT06408441
The Epithelioid Hemangioendothelioma Registry of the European Reference Network on Rare Adult Solid Cancers (EURACAN)
Research · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Maria Skłodowska-Curie Institute of Oncology, Warsaw
Registry updated 2026-04-03
NCT04498767
Stereotactic Body Radiotherapy in Patients With Rare Oligometastatic Cancers (OligoRARE)
Trial Treatment · European Organisation for Research and Treatment of Cancer - EORTC
Medical University Of Gdansk, Gdansk · Maria Sklodowska-Curie Memorial Cancer Centre - Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw
Registry updated 2024-08-26
2024-514441-11-00
To evaluate the efficacy and safety of naxitamab in patients with refractory Ewing's sarcoma.
Trial Treatment · Phase 2 · Instytut Matki I Dziecka
Instytut Matki i Dziecka, Warsaw · Uniwersytecki Szpital Kliniczny im Jana Mikulicza Radeckiego we Wroclawiu, Wroclaw
Registry updated 2024-08-06
NCT03838718
REtroperitoneal SArcoma Registry: an International Prospective Initiative
Research · Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw
Registry updated 2019-02-12

All Sarcoma trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error